@entity2204 allele status in korean @entity303 XXXX with severe @entity62 .

@entity1 @entity2204 @entity303 @entity1294 @entity195 @entity62
Few studies have investigated the @entity2204 ( @entity2204 )   4 allele status of @entity303 @entity1 with severe @entity62 ( @entity195 ). In this study, we aimed to characterize the @entity2204 epsivlon genotypes and clinical features of @entity303 @entity1 with severe @entity195 . Four hundred and thirty nine @entity1 with @entity303 and 152 subjects with normal cognition (NC) were recruited from multiple centers in Korea, known as the Clinical Research Center for @entity303 of South Korea (CREDOS), since November 2005. The @entity195 were rated using the scale that had been developed by the CREDOS study. @entity303 @entity1 with minimal @entity195 were considered to have @entity195 ( @entity195 ) without @entity195 ( @entity195 - @entity195 : 325), and those with severe @entity195 were considered to have Subcortical @entity1294 (SIVD: 50) or @entity195 with severe @entity195 ( @entity195 ). Comparisons of @entity2204 allelic prevalence were performed using chi-square analysis. The @entity2204 allele was more prevalent in those with @entity195 than in those with SIVD and NC (p < 0.001). It was not more prevalent in those with SIVD than in those with NC (p = 0.169). @entity2204 allele status in @entity195 + @entity195 did not differ from that in @entity195 - @entity195 (p = 0.625). The @entity2204 allele was more prevalent in those with @entity195 than in those with SIVD. @entity2204 may not be associated with SIVD although it is one of the vascular risk factors.
